Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
2.170
-0.020 (-0.91%)
At close: Apr 17, 2026, 4:00 PM EDT
2.150
-0.020 (-0.92%)
After-hours: Apr 17, 2026, 7:59 PM EDT
Replimune Group Stock Forecast
Stock Price Forecast
The 6 analysts that cover Replimune Group stock have a consensus rating of "Hold" and an average price target of $5.67, which forecasts a 161.29% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $14.
Price Target: $5.67 (+161.29%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Replimune Group stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
| Buy | 4 | 4 | 4 | 4 | 4 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 13, 2026 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $11 → $2 | Buy → Hold | Downgrades | $11 → $2 | -7.83% | Apr 13, 2026 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Apr 13, 2026 |
| Wedbush | Wedbush | Buy → Hold Downgrades $19 → $2 | Buy → Hold | Downgrades | $19 → $2 | -7.83% | Apr 13, 2026 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $13 → $2 | Strong Buy → Hold | Downgrades | $13 → $2 | -7.83% | Apr 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
62.29M
EPS This Year
-3.44
from -3.07
EPS Next Year
-2.36
from -3.44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | n/a | 173.4M | ||||
| Avg | n/a | 62.3M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -3.33 | -1.68 | ||||
| Avg | -3.44 | -2.36 | ||||
| Low | -3.44 | -2.87 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.